News - Alimera Sciences, Financial

Filter

Current filters:

Alimera SciencesFinancial

Popular Filters

Alimera's Iluvien approved in France for diabetic macular edema

19-07-2012

USA-based ophthalmic biopharma specialist Alimera Sciences (Nasdaq: ALIM) says that French regulator…

Alimera SciencesEuropeFinancialIluvienOphthalmicsPharmaceuticalRegulation

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top